Results 201 to 210 of about 14,865 (241)
Some of the next articles are maybe not open access.
Absence of xanthine oxidoreductase activity in human myocardium
Cardiovascular Research, 1991The aim was to examine whether or not xanthine oxidase activity may be a significant source of oxygen derived free radicals in the human heart.Xanthine oxidoreductase activity of human myocardium was assayed in vitro. In addition, tests were performed to assess whether or not endogenous inhibitors of the enzyme were present in myocardial homogenates ...
T, Podzuweit +5 more
openaire +4 more sources
Xanthine oxidoreductase and its inhibitors: relevance for gout
Clinical Science, 2016Xanthine oxidoreductase (XOR) is the rate-limiting enzyme in purine catabolism and converts hypoxanthine to xanthine, and xanthine into uric acid. When concentrations of uric acid exceed its biochemical saturation point, crystals of uric acid, in the form of monosodium urate, emerge and can predispose an individual to gout, the commonest form of ...
Richard O, Day +4 more
openaire +2 more sources
Xanthine Oxidoreductase Activities
2020Xanthine oxidoreductase (XOR) is the enzyme that catalyzes the oxidation of hypoxanthine to xanthine and xanthine to uric acid. XOR is widely distributed throughout living organisms and is highly conserved in prokaryotic, plant, and animal species. XOR activity is very versatile, generating both pro-oxidant (primarily within the cell) and anti-oxidant (
Letizia Polito +3 more
openaire +1 more source
Structure and Function of Xanthine Oxidoreductase
ChemInform, 2006AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
openaire +1 more source
Nucleosides, Nucleotides and Nucleic Acids, 2008
Inhibitors of xanthine oxidoreductase block conversion of xanthine to uric acid and are therefore potentially useful for treatment of hyperuricemia or gout. We determined the crystal structure of reduced bovine milk xanthine oxidoreductase complexed with oxipurinol at 2.0 A resolution.
Ken, Okamoto +4 more
openaire +2 more sources
Inhibitors of xanthine oxidoreductase block conversion of xanthine to uric acid and are therefore potentially useful for treatment of hyperuricemia or gout. We determined the crystal structure of reduced bovine milk xanthine oxidoreductase complexed with oxipurinol at 2.0 A resolution.
Ken, Okamoto +4 more
openaire +2 more sources
[Inhibitors of xanthine oxidoreductase].
Nihon rinsho. Japanese journal of clinical medicine, 2008Inhibitors of xanthine oxidoreductase decrease production of uric acid, thus they act as hypouricemic drugs. Allopurinol, a prototypical xanthine oxidoreductase inhibitor, has been widely prescribed for treatment of gout and hyperuricemia. However, severe side effects of allopurinol may occur in patients with renal insufficiency.
openaire +1 more source
1991
In normal cardiac tissue xanthine oxidoreductase is present in the dehydrogenase form. During ischemia xanthine dehydrogenase is converted to xanthine oxidase, which generates free radicals during reperfusion. Both forms catalyze the breakdown of hypoxanthine to xanthine and xanthine to urate.
M, Janssen +3 more
openaire +2 more sources
In normal cardiac tissue xanthine oxidoreductase is present in the dehydrogenase form. During ischemia xanthine dehydrogenase is converted to xanthine oxidase, which generates free radicals during reperfusion. Both forms catalyze the breakdown of hypoxanthine to xanthine and xanthine to urate.
M, Janssen +3 more
openaire +2 more sources
Xanthine oxidoreductase: dehydrogenase to oxidase conversion
Biochemical Society Transactions, 1997M G, Ryan +4 more
openaire +2 more sources
HISTORY OF MILK XANTHINE OXIDOREDUCTASE
Biochemical Society Transactions, 1997V. MASSEY, C. H. HARRIS
openaire +1 more source
Xanthine oxidoreductase. Biochemical, biological and pathogenic functions.
Sbornik lekarsky, 1996Primary biochemical role of xanthine oxidoreductase (XOR, EC 1.1.1.204 and EC 1.1.3.22.) is the hydroxylation of hypoxathine and xanthine to form uric acid. This enzyme may produce very reactive oxygen forms which can be pathogenic. Although it is one of the longest known and most continuously studied enzymes, its biological function remains unclear ...
S, Stipek +4 more
openaire +1 more source

